IL10 and myasthenia gravis: Another main finding of this study was the demonstration of IS treatment’s down-regulating effect on Th1 cytokines, such as IFN-γ and IL12p40 and up-regulating effect on IL-10 and IL-6, which implicated a mechanism of treatment-induced functional regulation in AChR-MG.